International Cardiovascular Research Journal

Scope & Guideline

Innovating heart health through rigorous research.

Introduction

Welcome to your portal for understanding International Cardiovascular Research Journal, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2251-9130
PublisherSHIRAZ UNIV MEDICAL SCIENCES, CARDIOVASCULAR RESEARCH CENTER
Support Open AccessNo
CountryIran
TypeJournal
Convergefrom 2011 to 2024
AbbreviationINT CARDIOVASC RES J / Int. Cardiovasc. Res. J.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMollasadra St., Khalili Ave., Research Tower, SHIRAZ 71934, IRAN

Aims and Scopes

The International Cardiovascular Research Journal focuses on advancing knowledge in cardiovascular health through a blend of clinical and experimental research. It aims to disseminate findings that contribute to the understanding, prevention, diagnosis, and treatment of cardiovascular diseases.
  1. Clinical Cardiovascular Research:
    The journal emphasizes clinical studies that investigate various aspects of cardiovascular disease, including diagnostics, treatment outcomes, and patient management strategies.
  2. Innovative Diagnostic Techniques:
    A strong focus on the development and evaluation of novel diagnostic methodologies, such as advanced imaging techniques and biomarker studies, is prevalent in the journal's publications.
  3. Epidemiological Studies:
    The journal frequently publishes research that examines the epidemiology of cardiovascular risk factors, providing insights into population health and disease prevalence.
  4. Interventional Cardiology:
    Research related to interventional procedures, including angioplasty and valve replacement, is extensively covered, highlighting advancements in surgical techniques and patient outcomes.
  5. Risk Factor Analysis:
    The journal explores various modifiable and non-modifiable risk factors contributing to cardiovascular diseases, offering insights into prevention and management strategies.
  6. Translational Research:
    It includes studies that bridge the gap between laboratory research and clinical application, focusing on molecular and genetic aspects of cardiovascular health.
Recent publications in the International Cardiovascular Research Journal reveal emerging trends and themes that indicate evolving areas of interest and research priorities within the field of cardiovascular health.
  1. Telemedicine and Remote Monitoring:
    The rise of telecardiology and remote patient monitoring is a significant trend, reflecting the need for innovative care delivery models, particularly post-pandemic.
  2. Impact of COVID-19 on Cardiovascular Health:
    A growing body of research is focusing on the cardiovascular implications of COVID-19, including the effects of the virus on existing heart conditions and the overall management of cardiovascular patients during the pandemic.
  3. Artificial Intelligence in Cardiology:
    The integration of AI and machine learning in cardiovascular research is becoming prominent, particularly in diagnostic imaging and predictive analytics for patient outcomes.
  4. Women’s Cardiovascular Health:
    There is an increasing focus on gender-specific cardiovascular issues, addressing the unique risk factors, presentations, and treatment responses in women.
  5. Genetic and Molecular Research:
    Emerging themes in genetic predispositions and molecular pathways related to cardiovascular disease are gaining traction, highlighting the importance of personalized medicine.

Declining or Waning

Over the years, certain themes within the International Cardiovascular Research Journal have shown a decline in frequency or prominence. This waning may reflect shifts in research focus or evolving clinical priorities.
  1. Traditional Cardiovascular Pharmacotherapy:
    Research centered on conventional pharmacological treatments has seen a decrease, possibly due to the emergence of novel therapies and personalized medicine approaches.
  2. Basic Science Studies:
    Although foundational, studies focusing solely on basic science without direct clinical implications are appearing less frequently, suggesting a trend towards more applied research.
  3. Non-Cardiovascular Related Comorbidities:
    Investigations into comorbid conditions that are not directly related to cardiovascular health have diminished, as the journal's focus narrows towards cardiovascular-specific research.
  4. Longitudinal Studies:
    Research with lengthy follow-up periods has become less common, likely due to the challenges of funding and participant retention over time.

Similar Journals

Archives of Cardiovascular Diseases

Advancing cardiovascular health through groundbreaking research.
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1875-2136Frequency: 12 issues/year

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Frontiers in Cardiovascular Medicine

Championing Breakthroughs in Heart Health Science.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Journal of the Practice of Cardiovascular Sciences

Shaping the Future of Cardiovascular Health Through Open Access
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

Cardiology and Therapy

Leading the way in cardiology research and innovation.
Publisher: SPRINGER LONDON LTDISSN: 2193-8261Frequency: 1 issue/year

Cardiology and Therapy, published by SPRINGER LONDON LTD, is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. With an ISSN of 2193-8261 and an E-ISSN of 2193-6544, this esteemed journal has been at the forefront of disseminating high-quality research since its inception in 2012. It has achieved an impressive Q1 ranking in the 2023 Cardiology and Cardiovascular Medicine category, reflecting its commitment to excellence and relevance in the field. Spanning a wide array of topics—from clinical studies to cutting-edge therapeutic interventions—the journal aims to foster knowledge exchange among researchers, clinicians, and healthcare professionals. In addition, its position in the 72nd percentile of Scopus rankings underscores its global impact and contribution to the cardiovascular research community. With open access options, Cardiology and Therapy ensures that its content is widely accessible, promoting the sharing of vital findings that can influence clinical practice and improve patient outcomes.

IJC Heart & Vasculature

Exploring Innovations in Heart and Vascular Research
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

TRENDS IN CARDIOVASCULAR MEDICINE

Advancing the Frontiers of Cardiovascular Research
Publisher: ELSEVIER SCIENCE LONDONISSN: 1050-1738Frequency: 8 issues/year

TRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.

CJC Open

Empowering research, enriching cardiovascular health.
Publisher: ELSEVIERISSN: 2589-790XFrequency:

CJC Open is a leading open access journal published by Elsevier, focused on advancing the fields of Cardiology and Cardiovascular Medicine. Since its inception in 2019, the journal has committed to disseminating high-quality research and groundbreaking advancements in cardiovascular health. With its ISSN 2589-790X and an impressive Q2 ranking in its field, CJC Open aims to foster collaboration and communication among researchers, healthcare professionals, and students by providing a platform for innovative studies, reviews, and insights. The journal is indexed in Scopus, currently ranking at #191 out of 387 in its category, underscoring its relevance and impact in the academic community. As an open access journal, CJC Open ensures that research findings are widely available, promoting greater visibility and readership. Scientists and practitioners alike are encouraged to submit their work, further enriching the discourse in cardiovascular research. With a focus on quality and accessibility, CJC Open is poised to make significant contributions to the field through 2024 and beyond.

Anatolian Journal of Cardiology

Advancing Cardiac Research Through Open Access Excellence.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

ACTA CARDIOLOGICA

Uniting professionals through groundbreaking cardiac studies.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Clinica e Investigacion en Arteriosclerosis

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.